MLchartDataset catalogue

Zymosan

Term · Oncology and biomedicine · MLC-T-ONC-017721

An insoluble beta-1,3-glucan polysaccharide derived from, and structural component of, yeast cell walls, with potential immunostimulating activity. Upon administration, zymosan targets, binds to and activates certain Toll-like receptors, primarily TLR type 2 (TLR-2), on leukocytes and dectin-1 on macrophages. Activation of TLR2 and dectin-1 stimulates the release of pro-inflammatory mediators, and enhances innate immune responses.

Table 1. Record
IdentifierMLC-T-ONC-017721
FieldOncology and biomedicine
AbbreviationZM
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017721",
  "term": "Zymosan",
  "field": "Oncology and biomedicine",
  "definition": "An insoluble beta-1,3-glucan polysaccharide derived from, and structural component of, yeast cell walls, with potential immunostimulating activity. Upon administration, zymosan targets, binds to and activates certain Toll-like receptors, primarily TLR type 2 (TLR-2), on leukocytes and dectin-1 on macrophages. Activation of TLR2 and dectin-1 stimulates the release of pro-inflammatory mediators, and enhances innate immune responses.",
  "abbreviation": "ZM",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/zymosan/"
}

Record 17,712 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.